Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: Analysis of feasibility and early toxicity

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages

  Marnitz, Simone ^a   Köhler, Christhardt ^a   Burova, Elena ^a   Wlodarczyk, Waldemar ^a   Jahn, Ulrich ^a   Grün, Arne ^a   Budach, Volker ^a   Stromberger, Carmen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cervical cancer; Chemoradiation; Helical tomotherapy; Simultaneous boost; Toxicity

Indexed keywords

CERVICAL CANCERS; CHEMORADIATION; CIS-PLATIN; DOSE ESCALATION; DOSE-VOLUME HISTOGRAMS; EFFECTIVE DOSE; GENITOURINARY TOXICITIES; HELICAL TOMOTHERAPY; HEMATOLOGIC TOXICITY; HIGH-DOSE RATE BRACHYTHERAPY; INTERNATIONAL FEDERATION; LOW RATES; LYMPH NODE REGION; MEAN DOSE; PATHOLOGIC RESPONSE; SIMULTANEOUS BOOST; SIMULTANEOUS INTEGRATED BOOSTS; SMALL BOWEL; TREATMENT TIME;

BLOOD VESSELS; CHEMOTHERAPY; DISEASES; DOSIMETRY; INTEGRATION; PATHOLOGY; PLATINUM COMPOUNDS; TOXICITY; TUMORS;

RADIOTHERAPY;

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER; BLADDER SPASM; BLOOD TOXICITY; BRACHYTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONSTIPATION; CURETTAGE; CYSTITIS; DEHYDRATION; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DYSURIA; ERYTHEMA; FEASIBILITY STUDY; FEMALE; FLATULENCE; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; ILEUS; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NAUSEA; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROCTITIS; PRURITUS; RADIATION DOSE; RECTUM; RECTUM HEMORRHAGE; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SMALL INTESTINE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TENESMUS; TREATMENT DURATION; TREATMENT RESPONSE; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION; UTERINE CERVIX CANCER; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINAL DRYNESS; VAGINITIS; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CHEMORADIOTHERAPY; CISPLATIN; DIARRHEA; FEASIBILITY STUDIES; FEMALE; FIDUCIAL MARKERS; HUMANS; INTESTINE, SMALL; LAPAROSCOPY; LEUKOPENIA; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PELVIS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RELATIVE BIOLOGICAL EFFECTIVENESS; THROMBOCYTOPENIA; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 84855860782     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.066     Document Type: Article

References (33)

1. T. Beck, P. Sukumvanich, and J. Rubatt Impact of the National Cancers Institute's clinical announcement on cervical cancer survival Gynecol Oncol 116 2010 S36
2. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
3. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecology Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
4. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
5. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
6. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration J Clin Oncol 26 2008 5802 5812
7. M. Chatani, T. Nose, and N. Masaki Adjuvant radiotherapy after radical hysterectomy of the cervical cancer Strahlenther Onkol 174 1998 504 509
8. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781 786
9. J.M. Kirwan, P. Symonds, and J.A. Green A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer Radiother Oncol 68 2003 217 226
10. B.M. Beadle, A. Jhingran, and S.S. Yom Patterns of regional recurrence after definitive radiotherapy for cervical cancer Int J Radiat Oncol Biol Phys 76 2010 1396 1403
11. D. Bodurka-Bevers, M. Morris, and P.J. Eifel Posttherapy surveillance of women with cervical cancer: An outcomes analysis Gynecol Oncol 78 2000 187 193
12. V. Zanagnolo, L. Ming, and A. Gadducci Surveillance procedures for patients with cervical carcinoma: A review of the literature Int J Gynecol Cancer 19 2009 194 201
13. E. Sartori, B. Pasinetti, and L. Carrara Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients Gynecol Oncol 107 2007 241 247
14. K. Vandecasteele, W. De Neve, and W. De Gersem Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer Strahlenther Onkol 185 2009 799 807
15. L. Portelance, K.S. Chao, and P.W. Grigsby Intensity- modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and paraaortic radiation Int J Radiat Biol Oncol Phys 51 2001 261 266
16. A.J. Mundt, J.C. Roeske, and A.E. Lujan Initial clinical experience with intensity-modulated whole pelvis radiation therapy in patients with gynaecologic malignancies Gynecol Oncol 82 2001 446 456
17. M.F. Chen, C.J. Tseng, and C.C. Tseng Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: Comparison with conventional radiotherapy Int J Radiat Oncol Biol Phys 67 2007 1438 1444
18. M.E. Randall, and G.S. Ibbott Intensity- modulated radiation therapy (IMRT) for gynaecologic cancers: Pitfalls, hazards, and cautions to be considered Semin Radiat Oncol 16 2006 138 143
19. J.C. Roeske, A. Lujan, and J. Rotmensch Intensity modulated whole pelvis therapy in patients with gynaecologic malignancies Int J Radiat Oncol Biol Phys 48 2000 1613 1621
20. J. Lian, M. Mackenzie, and K. Joseph Assessment of extended field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy Int J Radiat Oncol Biol Phys 70 2008 935 943
21. C.H. Hsieh, M.C. Wie, and H.-L. Lee Whole pelvic helical tomotherapy for locally advanced cervical cancer: Technical implementation of IMRT with helical tomotherapy Radiat Oncol 4 2009 62
22. S. Marnitz, C. Köhler, and C. Roth Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 99 2005 536 544
23. Common Terminology Criteria for Adverse Events v3.0. CTCAEv3.0: ctep.cancer.gov. Date accessed August 8, 2010.
24. Gerbaulet A, Pötter R, Haie-Meder C. The GEC-ESTRO handbook of brachytherapy. Cervix carcinoma. www.estro-education.org. Date accessed August 8, 2010.
25. S. Nag, and N. Gupta A simple method of obtaining equivalent doses for use brachytherapy Int J Radiat Oncol Biol Phys 46 2000 507 513
26. C.G. Orton Radiobiology S. Nag, Principles and practice of brachytherapy 1997 Futura Publishing Armonk, NY 27 45
27. S. Nag, and N. Gupta A simple method of obtaining equivalent doses for use in HDR brachytherapy Int J Radiat Oncol Biol Phys 46 2000 507 513
28. Uterus 11 Study. www.clinicalrial.org. Date accessed August 8, 2010.
29. M. Amneus, S. Park, and L. Delic Barriers to timely completion of primary chemoradiation for cervical cancer Gynecol Oncol 116 2010 34 35
30. C.L. Creutzberg, W.L. van Putten, and P.C. Koper PORTEC Study Group. The postoperative radiation therapy in endometrial carcinoma. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial Int J Radiat Oncol Biol Phys 51 2001 1246 1255
31. K.L. Baglan, R.C. Frazier, and D. Yan The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU based chemotherapy and radiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 52 2002 176 183
32. J.M. Robertson, D. Lockman, and D. Yan The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418
33. M.F. Chen, C.J. Tseng, and C.C. Tseng Adjuvant concurrent chemoradiotherapy with intensity modulated pelvic radiotherapy after surgery for high risk, early stage cervical cancer patents J Cancer 14 2008 200 206